THE INFLUENCE OF INFUSION RATE ON THE HEMODYNAMIC-EFFECTS OF FELODIPINE

被引:10
作者
COHEN, AF
VANHALL, MA
VANHARTEN, J
SCHOEMAKER, RC
JOHANSSON, P
BREIMER, DD
VISSER, R
EDGAR, B
机构
[1] Centre for Human Drug Research, Leiden University Hospital, Leiden
关键词
D O I
10.1038/clpt.1990.154
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hemodynamic effects of the calcium entry blocker felodipine were studied during and after different infusion rates. Eight healthy normotensive volunteers had their individual pharmacokinetics of felodipine determined, and they subsequently entered a double-blind, randomized, crossover study. Individualized infusions of felodipine were given by a computerized infusion pump to reach plasma concentrations of 6 ng/ml (15.6 nmol/L) after 20 minutes, to be sustained for 8 hours (fast infusion) or the same plasma concentration after 8 hours (slow infusion). Control infusions with saline and vehicle were given. Blood pressure, heart rate, ECG conduction times, and baroreceptor sensitivity by the Valsalva test were measured, as well as the plasma concentrations of felodipine. The infusion system used produced the expected plasma concentration-time profiles with higher plasma concentrations after the fast infusion until 8 hours. Both slow and fast infusion increased heart rate (< 0.05) and produced a similar decrease in diastolic blood pressure (< 0.05). Slow infusion therefore reduced blood pressure more effectively. The tachycardia after the fast infusion was more pronounced during the first hour of the infusion but was indistinguishable from the slow infusion later, when plasma concentrations were still significantly different. Baroreceptor responsiveness was diminished by both felodipine treatments. There was no obvious difference in side effects caused by the two infusion regimes. The initial tachycardia after felodipine can be diminished by a slow rate of administration of the drug with a similar effect on blood pressure. © 1990.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 50 条
  • [21] HEMODYNAMIC-EFFECTS OF A NEW VASODILATOR DRUG, FELODIPINE, IN HEALTHY-SUBJECTS
    JOHNSSON, G
    MURRAY, G
    TWEDDEL, A
    HUTTON, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (01) : 49 - 53
  • [22] SUSTAINED HEMODYNAMIC-EFFECTS OF FELODIPINE IN PATIENTS WITH CHRONIC CARDIAC-FAILURE
    TWEDDEL, AC
    MARTIN, W
    MCGHIE, AI
    HUTTON, I
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (06) : 689 - 694
  • [23] DIFFERENCES OF HEMODYNAMIC-EFFECTS OF NITRENDIPINE AND FELODIPINE IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    HALABI, A
    LINDE, M
    KIRCH, W
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : P342 - P342
  • [24] THE SYSTEMIC AND CORONARY HEMODYNAMIC-EFFECTS OF FELODIPINE IN PATIENTS WITH CORONARY HEART-DISEASE
    TWEDDEL, AC
    JOHNSSON, G
    PRINGLE, TH
    MURRAY, RG
    HUTTON, I
    [J]. EUROPEAN HEART JOURNAL, 1983, 4 (10) : 699 - 705
  • [25] ACUTE HEMODYNAMIC-EFFECTS OF ORAL FELODIPINE IN BETA-ADRENOCEPTOR BLOCKED PATIENTS
    CULLING, W
    SHERIDAN, DJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (02) : P206 - P207
  • [26] HEMODYNAMIC-EFFECTS OF FELODIPINE AT REST AND DURING EXERCISE IN EXERTIONAL ANGINA-PECTORIS
    DETRY, JMR
    DECOSTER, PM
    RENKIN, J
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (05) : 453 - 457
  • [27] EPINEPHRINE INFUSION IN SHEEP - SYSTEMIC AND RENAL HEMODYNAMIC-EFFECTS
    BERSTEN, AD
    RUTTEN, AJ
    SUMMERSIDES, G
    ILSLEY, H
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (06) : 994 - 1001
  • [28] HEMODYNAMIC-EFFECTS OF MORPHINE INFUSION IN VENTILATED PRETERM BABIES
    SABATINO, G
    QUARTULLI, L
    DIFABIO, S
    RAMENGHI, LA
    [J]. PEDIATRIC RESEARCH, 1995, 38 (03) : 453 - 453
  • [29] HEMODYNAMIC-EFFECTS OF MEXILETINE ON CONTINUOUS INTRAVENOUS-INFUSION
    BECK, E
    LEWKOWICZ, M
    CECCHI, A
    DEMARTINI, A
    [J]. REVISTA MEDICA DE CHILE, 1984, 112 (03) : 23 - 24
  • [30] INFLUENCE OF HEMODIALYSIS ON THE PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF NIFEDIPINE DURING CONTINUOUS INTRAVENOUS-INFUSION
    KLEINBLOESEM, CH
    VANBRUMMELEN, P
    WOITTIEZ, AJ
    FABER, H
    BREIMER, DD
    [J]. CLINICAL PHARMACOKINETICS, 1986, 11 (04) : 316 - 322